AR075354A1 - Glicopeptidos semisinteticos como agentes antibacteriales - Google Patents
Glicopeptidos semisinteticos como agentes antibacterialesInfo
- Publication number
- AR075354A1 AR075354A1 ARP090103380A ARP090103380A AR075354A1 AR 075354 A1 AR075354 A1 AR 075354A1 AR P090103380 A ARP090103380 A AR P090103380A AR P090103380 A ARP090103380 A AR P090103380A AR 075354 A1 AR075354 A1 AR 075354A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- amino
- monosaccharide
- compounds
- amino acid
- Prior art date
Links
- 102000002068 Glycopeptides Human genes 0.000 title abstract 5
- 108010015899 Glycopeptides Proteins 0.000 title abstract 5
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 150000002772 monosaccharides Chemical class 0.000 abstract 3
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000007385 chemical modification Methods 0.000 abstract 1
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002336 glycosamine derivatives Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000012948 isocyanate Substances 0.000 abstract 1
- 150000002513 isocyanates Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22016709P | 2009-06-24 | 2009-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR075354A1 true AR075354A1 (es) | 2011-03-30 |
Family
ID=41203726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090103380A AR075354A1 (es) | 2009-06-24 | 2009-09-02 | Glicopeptidos semisinteticos como agentes antibacteriales |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110015119A1 (https=) |
| EP (1) | EP2373694A1 (https=) |
| JP (1) | JP2012510999A (https=) |
| KR (1) | KR20110099028A (https=) |
| CN (1) | CN102307903A (https=) |
| AR (1) | AR075354A1 (https=) |
| AU (1) | AU2009322925A1 (https=) |
| CA (1) | CA2745446A1 (https=) |
| GB (1) | GB2465863A (https=) |
| IL (1) | IL213390A0 (https=) |
| TW (1) | TW201021805A (https=) |
| WO (1) | WO2010065174A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011140009A1 (en) * | 2010-05-04 | 2011-11-10 | Biomarin Pharmaceutical Inc. | Methods of using semi-synthetic glycopeptides as antibacterial agents |
| CN107325159A (zh) | 2016-04-29 | 2017-11-07 | 中国科学院上海药物研究所 | 一类万古霉素衍生物、其制备方法、药物组合物和用途 |
| GB2577420B (en) | 2017-05-22 | 2022-07-06 | Insmed Inc | Glycopeptide derivative compounds and uses thereof |
| CN109422800A (zh) * | 2017-08-22 | 2019-03-05 | 复旦大学 | 抗革兰氏阳性菌季铵盐糖肽类化合物及其药用用途 |
| CN111793076B (zh) * | 2020-06-05 | 2021-10-12 | 华北制药河北华民药业有限责任公司 | 一种注射用硫酸头孢匹罗的制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0662674B2 (ja) * | 1985-01-11 | 1994-08-17 | 三共株式会社 | 抗生物質クロロポリスポリンｂまたはｃ |
| US4643987A (en) * | 1985-08-14 | 1987-02-17 | Eli Lilly And Company | Modified glycopeptides |
| NZ509165A (en) * | 1998-07-14 | 2003-08-29 | Univ Princeton | Glycopeptide antobiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| DE69908819T2 (de) * | 1998-12-23 | 2004-05-06 | Theravance, Inc., South San Francisco | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten |
| AU4054900A (en) * | 1999-04-02 | 2000-10-23 | Advanced Medicine East, Inc. | Desleucyl glycopeptide antibiotics and methods of making same |
| MXPA02006029A (es) * | 1999-12-15 | 2004-08-23 | Cubist Pharm Inc | Lipopeptidos novedosos como agentes antibacterianos. |
| US6397405B1 (en) * | 2000-04-11 | 2002-06-04 | Thetford Corporation | Flush toilet for RV's and boats |
| US6770621B2 (en) * | 2000-05-02 | 2004-08-03 | Theravance, Inc. | Polyacid glycopeptide derivatives |
| UA75083C2 (uk) * | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Похідні глікопептидфосфонатів |
| US6620781B2 (en) * | 2000-06-22 | 2003-09-16 | Theravance, Inc. | Glycopeptide carboxy-saccharide derivatives |
| US20030008812A1 (en) * | 2001-02-02 | 2003-01-09 | Christensen Burton G. | Glycopeptide derivatives |
| TWI233932B (en) * | 2001-08-24 | 2005-06-11 | Theravance Inc | Process for purifying glycopeptide phosphonate derivatives |
| US7521418B2 (en) * | 2003-05-27 | 2009-04-21 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| CA2588285A1 (en) * | 2004-11-29 | 2006-06-01 | National University Corporation Nagoya University | Glycopeptide antibiotic monomer derivatives |
| US7632918B2 (en) * | 2005-02-28 | 2009-12-15 | Novartis Vaccines And Diagnostics, Inc. | Semi-synthetic glycopeptides with antibiotic activity |
| US20070185015A1 (en) * | 2005-02-28 | 2007-08-09 | Chiron Corporation and North China Pharmaceutical Corporation | Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US7368422B2 (en) * | 2005-02-28 | 2008-05-06 | Novartis Vaccines And Diagnostics Inc. | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US8236926B2 (en) * | 2006-09-06 | 2012-08-07 | Wisconsin Alumni Research Foundation | Rapid glycopeptide optimization via neoglycosylation |
| WO2008075684A1 (ja) * | 2006-12-19 | 2008-06-26 | Shionogi & Co., Ltd. | グリコペプチド抗生物質誘導体 |
| GB2449156B8 (en) * | 2007-05-08 | 2010-06-02 | Lead Therapeutics Inc | Semi-synthetic glycopeptides with antibacterial activity. |
| US20090062268A1 (en) * | 2007-08-27 | 2009-03-05 | Lead Therapeutics, Inc. | Novel inhibitors of poly(adp-ribose)polymerase (parp) |
| CN101959849A (zh) * | 2007-12-26 | 2011-01-26 | 利德治疗公司 | 作为抗菌剂的新型半合成糖肽 |
| US20100105607A1 (en) * | 2008-10-24 | 2010-04-29 | Lead Therapeutics, Inc. | Novel semi-synthetic glycopeptides as antibacterial agents |
| US20100216699A1 (en) * | 2009-02-09 | 2010-08-26 | Lead Therapeutics, Inc. | Semi-synthetic glycopeptides having antibacterial activity |
-
2008
- 2008-12-05 GB GB0915258A patent/GB2465863A/en not_active Withdrawn
-
2009
- 2009-09-01 AU AU2009322925A patent/AU2009322925A1/en not_active Abandoned
- 2009-09-01 CA CA2745446A patent/CA2745446A1/en not_active Abandoned
- 2009-09-01 CN CN2009801561496A patent/CN102307903A/zh active Pending
- 2009-09-01 KR KR1020117015395A patent/KR20110099028A/ko not_active Withdrawn
- 2009-09-01 US US12/552,221 patent/US20110015119A1/en not_active Abandoned
- 2009-09-01 EP EP09830765A patent/EP2373694A1/en not_active Withdrawn
- 2009-09-01 WO PCT/US2009/055633 patent/WO2010065174A1/en not_active Ceased
- 2009-09-01 JP JP2011539532A patent/JP2012510999A/ja active Pending
- 2009-09-02 AR ARP090103380A patent/AR075354A1/es not_active Application Discontinuation
- 2009-09-02 TW TW098129618A patent/TW201021805A/zh unknown
-
2011
- 2011-06-05 IL IL213390A patent/IL213390A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009322925A1 (en) | 2011-06-30 |
| GB0915258D0 (en) | 2009-10-07 |
| KR20110099028A (ko) | 2011-09-05 |
| CA2745446A1 (en) | 2010-06-10 |
| US20110015119A1 (en) | 2011-01-20 |
| GB2465863A (en) | 2010-06-09 |
| JP2012510999A (ja) | 2012-05-17 |
| IL213390A0 (en) | 2011-07-31 |
| TW201021805A (en) | 2010-06-16 |
| EP2373694A1 (en) | 2011-10-12 |
| WO2010065174A1 (en) | 2010-06-10 |
| CN102307903A (zh) | 2012-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR071552A1 (es) | Glicopeptidos semisinteticos como agentes antibacterianos | |
| WO2009046314A3 (en) | Moenomycin analogs, methods of synthesis, and uses thereof | |
| AR075354A1 (es) | Glicopeptidos semisinteticos como agentes antibacteriales | |
| UY31164A1 (es) | Nuevos derivados de bencimidazol, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| NO20092476L (no) | Antibakterielle polycykliske ureaforbindelser | |
| BRPI0815708A8 (pt) | composto derivado de benzilbenzeno como inibidor de sglt, composição farmacêutica, e, uso de um composto | |
| BRPI0922220A8 (pt) | Uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos | |
| MX2009007730A (es) | Polimorfos macrocilicos, composiciones que comprenden tales polimorfos, y metodos para su uso y fabricacion. | |
| PH12012500698A1 (en) | Process for the preparation of compounds useful as inhibitors of sglt2 | |
| SG153833A1 (en) | Methods of treatment of endobronchial infections | |
| DOP2010000218A (es) | Inhibidores de beta-lactamasa | |
| BRPI0813450B8 (pt) | composto, formulação farmacêutica, e, usos do composto | |
| MX2014001600A (es) | 3,4-dihidro-1h-[1,8]naftiridinosas antibacterianas sustituidas con ciclopenta[c]pirrol. | |
| BR112014002958A2 (pt) | "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso". | |
| CL2013002313A1 (es) | Compuestos macrólidos derivados de eritromicina sustituidos en posición c-4” con metil amino sustituido con actividad antibiótica; compuestos intermediarios; composición farmacéutica, uso en profilaxis o tratamiento de infecciones bacterianas resistentes a la eritromicina. | |
| NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
| AR066345A1 (es) | Glucopeptidos semisinteticos con actividad antibacteriana | |
| CL2009001345A1 (es) | Compuestos derivados de 1-piridin-2-il-urea y 1-pirimidin-2-il-urea sustituidos, inhibidores de adn girasa y topoisomerasa iv; composicion farmaceutica; y su uso en tratamiento de infecciones bacterianas como neumonia adquirida intrahospitalariamente, infecciones a la piel, bronquitis, sinusitis, entre otras enfermedades. | |
| BRPI0607702A2 (pt) | composto, composição farmacêutica, uso do referido composto, e método de preparação de um composto | |
| MX2011013869A (es) | Agentes antihelminticos y su uso. | |
| AR073917A1 (es) | Sinergismo antibiotico | |
| CR9991A (es) | Nuevo derivado de pleuromutilina y su uso | |
| WO2006093933A3 (en) | Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity | |
| WO2006094082A3 (en) | Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity | |
| ECSP088132A (es) | INHIBIDORES DE 6-ALQUILIDENO-PENEME B-LACTAMASA BICÍCLICOS Y COMBINACIÓN ANTIBIÓTICA DE ß-LACTAMA: UN ANTIBIÓTICO DE AMPLIO ESPECTRO |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |